Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2006 2
2007 3
2008 3
2009 2
2010 4
2011 8
2012 7
2013 6
2014 5
2015 31
2016 36
2017 31
2018 7
2019 3
2020 4
2021 9
2022 8
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Approach to Kidney Biopsy: Core Curriculum 2022.
Najafian B, Lusco MA, Alpers CE, Fogo AB. Najafian B, et al. Am J Kidney Dis. 2022 Jul;80(1):119-131. doi: 10.1053/j.ajkd.2021.08.024. Epub 2022 Feb 4. Am J Kidney Dis. 2022. PMID: 35125261 Review.
Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathy.
Braun F, Abed A, Sellung D, Rogg M, Woidy M, Eikrem O, Wanner N, Gambardella J, Laufer SD, Haas F, Wong MN, Dumoulin B, Rischke P, Mühlig A, Sachs W, von Cossel K, Schulz K, Muschol N, Gersting SW, Muntau AC, Kretz O, Hahn O, Rinschen MM, Mauer M, Bork T, Grahammer F, Liang W, Eierhoff T, Römer W, Hansen A, Meyer-Schwesinger C, Iaccarino G, Tøndel C, Marti HP, Najafian B, Puelles VG, Schell C, Huber TB. Braun F, et al. Among authors: najafian b. J Clin Invest. 2023 Jun 1;133(11):e157782. doi: 10.1172/JCI157782. J Clin Invest. 2023. PMID: 37014703 Free PMC article.
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes.
Kobayashi H, Looker HC, Satake E, D'Addio F, Wilson JM, Saulnier PJ, Md Dom ZI, O'Neil K, Ihara K, Krolewski B, Badger HS, Petrazzuolo A, Corradi D, Galecki A, Wilson PC, Najafian B, Mauer M, Niewczas MA, Doria A, Humphreys BD, Duffin KL, Fiorina P, Nelson RG, Krolewski AS. Kobayashi H, et al. Among authors: najafian b. Sci Transl Med. 2022 Aug 10;14(657):eabj2109. doi: 10.1126/scitranslmed.abj2109. Epub 2022 Aug 10. Sci Transl Med. 2022. PMID: 35947673 Free PMC article.
AJKD Atlas of Renal Pathology: Cystinosis.
Lusco MA, Najafian B, Alpers CE, Fogo AB. Lusco MA, et al. Among authors: najafian b. Am J Kidney Dis. 2017 Dec;70(6):e23-e24. doi: 10.1053/j.ajkd.2017.10.002. Am J Kidney Dis. 2017. PMID: 29169518 Review. No abstract available.
AJKD Atlas of Renal Pathology: 2,8-Dihydroxyadeninuria.
Lusco MA, Fogo AB, Najafian B, Alpers CE. Lusco MA, et al. Among authors: najafian b. Am J Kidney Dis. 2017 Mar;69(3):e15-e16. doi: 10.1053/j.ajkd.2017.01.003. Am J Kidney Dis. 2017. PMID: 28236886 Review. No abstract available.
AJKD Atlas of Renal Pathology: Oxalosis.
Fogo AB, Lusco MA, Najafian B, Alpers CE. Fogo AB, et al. Among authors: najafian b. Am J Kidney Dis. 2017 Mar;69(3):e13-e14. doi: 10.1053/j.ajkd.2017.01.006. Am J Kidney Dis. 2017. PMID: 28236885 Review. No abstract available.
AJKD Atlas of Renal Pathology: Pierson Syndrome.
Lusco MA, Najafian B, Alpers CE, Fogo AB. Lusco MA, et al. Among authors: najafian b. Am J Kidney Dis. 2018 Apr;71(4):e3-e4. doi: 10.1053/j.ajkd.2018.02.001. Am J Kidney Dis. 2018. PMID: 29579420 Review. No abstract available.
AJKD Atlas of Renal Pathology: Bile Nephrosis.
Lusco MA, Fogo AB, Najafian B, Alpers CE. Lusco MA, et al. Among authors: najafian b. Am J Kidney Dis. 2017 Feb;69(2):e9. doi: 10.1053/j.ajkd.2016.12.001. Am J Kidney Dis. 2017. PMID: 28115067 Review. No abstract available.
AJKD Atlas of Renal Pathology: Fibronectin Glomerulopathy.
Lusco MA, Chen YP, Cheng H, Dong HR, Najafian B, Alpers CE, Fogo AB. Lusco MA, et al. Among authors: najafian b. Am J Kidney Dis. 2017 Nov;70(5):e21-e22. doi: 10.1053/j.ajkd.2017.09.001. Am J Kidney Dis. 2017. PMID: 29055354 Review. No abstract available.
Venglustat, an orally administered glucosylceramide synthase inhibitor: Assessment over 3 years in adult males with classic Fabry disease in an open-label phase 2 study and its extension study.
Deegan PB, Goker-Alpan O, Geberhiwot T, Hopkin RJ, Lukina E, Tylki-Szymanska A, Zaher A, Sensinger C, Gaemers SJM, Modur V, Thurberg BL, Sharma J, Najafian B, Mauer M, DasMahapatra P, Wilcox WR, Germain DP. Deegan PB, et al. Among authors: najafian b. Mol Genet Metab. 2023 Feb;138(2):106963. doi: 10.1016/j.ymgme.2022.11.002. Epub 2022 Nov 9. Mol Genet Metab. 2023. PMID: 36481125 Free PMC article. Clinical Trial.
162 results